ADC THERAPEUTICS SA (ADCT) Stock Analyst Earnings Estimates
NYSE:ADCT - New York Stock Exchange, Inc. - CH0499880968 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 33.9M | 209.9M 519.17% | 69.558M -66.86% | 74.135M 6.58% | 82.869M 11.78% | 115.07M 38.86% | 166.01M 44.27% | 261.86M 57.74% | 320.18M 22.27% | 376.44M 17.57% | 400.65M 6.43% | |
| EBITDA YoY % growth | -267.17M -23.03% | -118.57M 55.62% | -164.799M -38.99% | -140.76M 14.59% | -169.32M -20.29% | -162.18M 4.22% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -269.8M -23.03% | -120.9M 55.19% | -165.986M -37.29% | -139.902M 15.71% | -167.922M -20.03% | -146.919M 12.51% | -100.498M 31.60% | -22.954M 77.16% | 17.879M 177.89% | 61.226M 242.45% | 73.178M 19.52% | |
| Operating Margin | -795.87% | -57.60% | -238.63% | -188.71% | -202.64% | -127.68% | -60.54% | -8.77% | 5.58% | 16.26% | 18.26% | |
| EPS YoY % growth | -2.80 17.65% | -2.01 28.21% | -2.93 -45.77% | -1.74 40.57% | -1.62 6.95% | -1.16 28.55% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.44 57.58% | -0.49 12.57% | -0.50 -31.53% | -0.48 -15.36% | -0.41 6.61% |
| Revenue Q2Q % growth | 19.111M 13.82% | 19.074M 5.66% | 19.584M 12.49% | 20.604M 11.59% | 21.624M 13.15% |
| EBITDA Q2Q % growth | -40.8M 75.24% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -40.204M 75.78% | -40.596M -20.77% | -41.412M -42.60% | -41.616M -17.02% | -42.126M -4.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.42 27.59% | -0.40 | -0.02 | -4.24% |
| Q2 2024 Q2Q % growth | -0.38 34.48% | -0.47 | 0.09 | 18.56% |
| Q1 2024 Q2Q % growth | -0.56 24.32% | -0.57 | 0.01 | 1.20% |
| Q4 2023 Q2Q % growth | -1.03 -243.33% | -0.51 | -0.52 | -100.76% |
| Q3 2023 Q2Q % growth | -0.58 10.77% | -0.65 | 0.07 | 10.34% |
| Q2 2023 Q2Q % growth | -0.58 30.95% | -0.47 | -0.11 | -24.39% |
| Q1 2023 Q2Q % growth | -0.74 -236.36% | -0.68 | -0.06 | -8.28% |
| Q4 2022 Q2Q % growth | -0.30 33.33% | -0.29 | -0.01 | -2.55% |
| Q3 2022 Q2Q % growth | -0.65 30.11% | -0.36 | -0.29 | -80.60% |
| Q2 2022 Q2Q % growth | -0.84 12.50% | -0.93 | 0.09 | 9.90% |
| Q1 2022 Q2Q % growth | -0.22 52.17% | -0.71 | 0.49 | 69.00% |
| Q4 2021 Q2Q % growth | -0.45 57.14% | -0.87 | 0.42 | 48.53% |
| Q3 2021 Q2Q % growth | -0.93 -20.78% | -0.94 | 0.01 | 0.59% |
| Q2 2021 Q2Q % growth | -0.96 -31.51% | -0.88 | -0.08 | -9.44% |
| Q1 2021 Q2Q % growth | -0.46 32.35% | -0.92 | 0.46 | 50.17% |
| Q4 2020 Q2Q % growth | -1.05 | -0.39 | -0.66 | -168.54% |
| Q3 2020 Q2Q % growth | -0.77 | -0.83 | 0.06 | 6.80% |
| Q2 2020 Q2Q % growth | -0.73 | -0.66 | -0.07 | -10.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 18.464M 27.40% | 18.831M | -367K | -1.95% |
| Q2 2024 Q2Q % growth | 17.41M -9.71% | 19.174M | -1.764M | -9.20% |
| Q1 2024 Q2Q % growth | 18.053M -4.94% | 18.464M | -411K | -2.23% |
| Q4 2023 Q2Q % growth | 16.79M -75.95% | 15.633M | 1.157M | 7.40% |
| Q3 2023 Q2Q % growth | 14.493M -81.01% | 15.461M | -968K | -6.26% |
| Q2 2023 Q2Q % growth | 19.283M 11.53% | 42.386M | -23.103M | -54.51% |
| Q1 2023 Q2Q % growth | 18.992M -59.16% | 20.49M | -1.498M | -7.31% |
| Q4 2022 Q2Q % growth | 69.8M 310.35% | 66.798M | 3.002M | 4.49% |
| Q3 2022 Q2Q % growth | 76.32M 480.38% | 47.947M | 28.373M | 59.18% |
| Q2 2022 Q2Q % growth | 17.29M 359.84% | 20.925M | -3.635M | -17.37% |
| Q1 2022 Q2Q % growth | 46.5M | 29.516M | 16.984M | 57.54% |
| Q4 2021 Q2Q % growth | 17.01M | 16.787M | 223K | 1.33% |
| Q3 2021 Q2Q % growth | 13.15M | 7.534M | 5.616M | 74.54% |
| Q2 2021 Q2Q % growth | 3.76M | 2.27M | 1.49M | 65.64% |
| Q1 2021 Q2Q % growth | 96.217K | -96.217K | -100.00% | |
| Q4 2020 Q2Q % growth | 875.16K | -875.16K | -100.00% | |
| Q3 2020 Q2Q % growth | 43.523K | -43.523K | -100.00% | |
| Q2 2020 Q2Q % growth | -100.00% | 305.49K | -305.49K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 298.35K | -298.35K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 11.29% | 0% | 62.88% |
| Revenue | 0% | -7.7% | 0% | 0% |